U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H10O2
Molecular Weight 102.1317
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETHYL PROPIONATE

SMILES

CCOC(=O)CC

InChI

InChIKey=FKRCODPIKNYEAC-UHFFFAOYSA-N
InChI=1S/C5H10O2/c1-3-5(6)7-4-2/h3-4H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C5H10O2
Molecular Weight 102.1317
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Ethyl propionate causes topical dissolution of cholesterol gallbladder. It was tested on an animal model of gallstones in 1997, however, there is no information about its further development.

Approval Year

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
In a preclinical study, ethyl propionate was infused intraduodenally for 3 hr in 32 male New Zealand rabbits.
Route of Administration: Other
In Vitro Use Guide
Human cholesterol gallstones were put in separate glass test tubes, hepatic bile (2 ml) was added and gallstones were subsequently dissolved in 8 ml of either ethyl propionate or ethyl propionate/dimethyl sulphoxide (70/30). The in vivo situation was mimicked by creating turbulence manually using glass syringes (4-6 cycles a minute) and by exchanging solvents and bile every 15 minutes. Test tubes were incubated in the dark at 37 degrees Celsius. No cholesterol stone dissolved completely within the frame of 300 minutes, leaving a mean stone residue of 35% in ethyl propionate and 28% ethyl propionate/dimethyl sulphoxide mixture.
Substance Class Chemical
Record UNII
AT9K8FY49U
Record Status Validated (UNII)
Record Version